What is NDC 0480-3325?

0480-3325 is the product NDC for Dalbavancin, Dalbavancin hydrochloride 500 mg/25mL injection, powder, for solution, listed with the FDA by Teva Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals, Inc., NDC labeler code 0480. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dalbavancin?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dalbavancin NDC 0480-3325 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0480-3325Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00480-3325Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0480-3325-01	0048033250100480332501	1 VIAL in 1 CARTON (0480-3325-01) / 25 mL in 1 VIALMarketed from Oct 29, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dalbavancin
Generic name (nonproprietary): dalbavancin
Active ingredients: Dalbavancin hydrochloride — 500 mg/25mL
Dosage form: Injection, Powder, For solution
Route: Intravenous
Labeler: Teva Pharmaceuticals, Inc.NDC labeler code 0480
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219465
Marketing start: Oct 29, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Lipoglycopeptides (Chemical structure)
Identifiers: Product ID 0480-3325_7fddacee-2401-4514-acf0-3847da11c6e5SPL ID 7fddacee-2401-4514-acf0-3847da11c6e5SPL set ID 1f4a5924-96d7-445a-b75f-2c0e1ffd2deaRxCUI 1539243UNII 33WDQ7T81E
Pharmacologic class: Lipoglycopeptide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400480332501 followed by a unit qualifier and the quantity

Package 00480-3325-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 6, 2025.

Indications (excerpt from the label)

1 INDICATION AND USAGE Dalbavancin for injection is a lipoglycopeptide antibacterial indicated for the treatment of adult and pediatric patients with acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible strains of Gram-positive microorganisms. ( 1.1 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of dalbavancin for injection and other antibacterial drugs, dalbavancin for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. ( 1.2 ) 1.1 Acute Bacterial Skin and Skin Structure Infections Dalbavancin for injection is indicated for the t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0480-3325

What is NDC 0480-3325?: 0480-3325 is the product NDC for Dalbavancin, Dalbavancin hydrochloride 500 mg/25mL injection, powder, for solution, listed with the FDA by Teva Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dalbavancin.
What is the active ingredient?: Dalbavancin hydrochloride.
Who is the labeler?: Teva Pharmaceuticals, Inc., NDC labeler code 0480. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dalbavancin?: 4 other product NDCs are listed under this name. See all Dalbavancin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dalbavancin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dalbavancin	Dalbavancin hydrochloride 500 mg/25mL	Injection, Powder, Lyophilized, For solutionIntravenous	Somerset Therapeutics, LLC	70069-830	70069-0830-01
Dalbavancin	Dalbavancin hydrochloride 500 mg/25mL	Injection, Powder, Lyophilized, For solutionIntravenous	BE Pharmaceuticals Inc.	71839-144	71839-0144-01
Dalbavancindalbavancin hydrochloride	Dalbavancin hydrochloride 500 mg/1	Injection, Powder, For solutionIntravenous	Long Grove Pharmaceuticals, LLC	81298-2390	81298-2390-01
Dalbavancin	Dalbavancin hydrochloride 500 mg/25mL	Injection, Powder, Lyophilized, For solutionIntravenous	Meitheal Pharmaceuticals Inc	71288-034	71288-0034-50